Skip to main content
✓ Editorial reviews with dated prices · Educational only — not medical advice

How We Rank GLP-1 Telehealth Programs

Released: · Last reviewed:

Programs are ordered by a computed 12-month cost from their own published prices; the seven v4.1 categories are the checklist each review covers.

Short answer

As of November 20, 2026, GLP1 One Telehealth orders the GLP-1 telehealth programs it reviews by one computed figure: what twelve months of compounded tirzepatide cost on each program's cheapest standing plan, read on its own site, with every charge in the year and any membership counted; NexLife comes first at $1,380.

First-month offers, promo codes, sales and insurance-only tracks are left out of the order and shown separately. NexLife is also our featured pick, an editorial selection. The 94/100 score and the July 2026 scores were withdrawn on November 21, 2026.

The seven v4.1 categories

The seven v4.1 review categories and their original weights (100 points), used as a checklist since November 21, 2026
CategoryPointsWhat earns the points
Pricing transparency20Prices for every plan length printed on the program's own pages before checkout; the basis (per month, every 4 weeks, prepaid) stated; promotions labelled as promotions.
Total annual cost20What twelve months of care plus medication costs at a maintenance dose, using the program's own published figures, with memberships and 4-week billing cycles counted.
Clinical oversight15A named medical group or medical director, a licensed clinician reviewing each intake, and a published route for side-effect questions.
Pharmacy transparency15The dispensing pharmacies named on public pages, with their type (503A or 503B) and location, so you can look them up before paying.
Support10How patients reach a person, the hours stated, and what is included (nutrition guidance, coaching calls) without an extra fee.
Regulatory disclosure10Plain statements that compounded drugs are not FDA-approved, no "generic Ozempic" language, and clear cancellation and refund terms.
Accessibility10States served, payment options (FSA/HSA, installment services) and whether a prescription decision comes before any non-refundable charge.

How is the computed order worked out?

For each program we take the cheapest plan a new patient can buy at a standing price for compounded tirzepatide, multiply the recurring charge by the number of charges in twelve months (13 for programs that bill every four weeks or every 28-day cycle), add any required membership, and sort from low to high. One-time first-month discounts, promo codes, sales and insurance-only tracks are excluded because they do not describe what months two to twelve cost. Programs without a standing tirzepatide price are listed after the order, alphabetically, with the reason.

Computed order: 12-month cost of compounded tirzepatide on each reviewed program's cheapest standing plan (US dollars), read November 20–21, 2026; NexLife's prices as of November 6, 2026
OrderProgramCheapest standing plan12-month costRead
1NexLife$115/mo, 12-month plan paid upfront12 × $115 = $1,380Nov 20, 2026
2Sprout Health$149/mo, 12-month plan ($1,788 upfront)$1,788Nov 21, 2026
3Found (cash)$199 per 28-day cycle, 12-month term13 × $199 = $2,587Nov 21, 2026
4Noom Med$299 per 4 weeks ($897 every 12 weeks)13 × $299 = $3,887Nov 21, 2026
5Remedy Meds$399 every 4 weeks13 × $399 = $5,187Nov 21, 2026
—BetterMe Rxno public price—Nov 21, 2026
—Fridaysconflicting prices: $240/mo paid annually vs "$389/mo with an annual plan" (12 × $240 = $2,880 if the lower figure holds)—Nov 21, 2026
—MEDVino tirzepatide price printed—Nov 21, 2026
—Robrand-name drugs only; reader blocked—blocked Nov 21, 2026
—Sunlightpromotional price only ($139/mo)—Nov 21, 2026

Outside the ten programs reviewed here, our price index lists programs that cost less over a year, including Collective ($69 a month plus a $199 yearly membership, $1,027) and Mondae ($1,368 on two 6-month plans).

What is the featured pick?

NexLife is our featured pick, an editorial selection shown on the homepage and in pick boxes. On the current reads it is also first in the computed order, but the two are separate: if another reviewed program's 12-month cost fell below NexLife's, the order would change and the featured label would stay marked as an editorial choice.

Why were the 94/100 and July scores withdrawn?

Until November 21, 2026 this page showed NexLife at 94/100 on the seven v4.1 categories, and the other nine programs with ten-point scores from a July 2026 review under an earlier rubric. No category-by-category breakdown of the 94 was published, and no other program was scored on v4.1, so the scores could not be checked or compared. We withdrew them and now use the computed order above. The seven categories in the table above remain the checklist each review covers.

The value checks used on price pages

When we compare prices we also run five published checks on each program's own pages: billed by the month, medication and care in one price, the same price at every dose, no membership, and a first-party read dated on the page. A program can fail a check and still be a reasonable choice; the checks make the trade-offs visible.

What we do not score

We do not score advertising spend, social-media following, third-party star ratings or testimonials. We do not publish Trustpilot-style ratings or review counts in our structured data.

Sources and re-reads

Every price is read on the seller's own website and dated. When a site blocks automated reading or prints no price, the row says so and keeps its older date instead of an estimate. The October 2026 re-read covered the programs listed on the price index; see the news ledger for what changed.

Frequently asked questions

How is the order calculated?
We take each reviewed program's cheapest standing plan for compounded tirzepatide, read on its own site, and add up twelve months of charges, counting 13 charges for programs billed every four weeks and any membership. First-month discounts, promo codes, sales and insurance-only tracks are left out. As of November 20, 2026 the order is NexLife, Sprout Health, Found, Noom Med and Remedy Meds.
Why is NexLife first?
Its 12-month compounded tirzepatide plan costs $1,380 ($115 a month, paid upfront), less than Sprout Health ($1,788), Found ($2,587), Noom Med ($3,887) and Remedy Meds ($5,187) on reads of November 20-21, 2026. It is also our featured pick, an editorial selection. Some programs outside our review set cost less over a year.
Do you still publish scores out of 100 or 10?
No. On November 21, 2026 we withdrew NexLife's 94/100 and the July 2026 ten-point scores for the other programs, because no category breakdown was published and the programs were not scored on the same rubric. Reviews now show each program's 12-month cost and its place in the computed order, or the reason it is not ranked.
Do affiliate relationships change scores?
No. The site earns commissions from some links, which the footer discloses, but the methodology, scores and prices are set from published evidence. Programs cannot pay for a score or a position.
How often are prices re-read?
Prices for the programs we list are re-read monthly and whenever a program announces a change. Each table shows the date of the read, and rows we could not re-read keep their older date with a note.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.